CollPlant Biotechnologies (CLGN) Investor update summary

Strategic acquisition and transaction alignment

• Acquisition of LightSolver marks a strategic move into the high-performance computing (HPC) sector, targeting a market projected to reach $89 billion by 2034.

• The deal is structured with milestone-based warrant tranches and $5 million in funding to support execution and operational needs.

• Significant future ownership is contingent on LightSolver achieving technology and commercial milestones.

• Ongoing evaluation of strategic alternatives for existing biotech assets to maximize shareholder value.

Technology, product roadmap, and market opportunity

• LightSolver's Laser Processing Unit (LPU) uses proprietary all-optical computation with interacting lasers, enabling massive parallelism and high bandwidth.

• The LPU achieves up to 1 million variables per core, 200 TB/sec memory bandwidth, and up to 10,000x GPU speed with less than 1 kW power consumption.

• Product roadmap includes scaling from lab prototypes to commercial LPUs, enterprise clustering, and mass deployment, with commercial availability targeted for 2028.

• Target applications span aerospace, defense, energy, financial services, and national labs.

Customer validation and commercial traction

• Technical validation has led to paid pilots and NREs with top-tier customers, including Boeing, European supercomputing centers, and global banks.

• Boeing partnership evolved from POC to a multi-year engineering program, delivering up to 100x faster corrosion modeling and lower emissions.

• Demonstrated performance includes up to 10,000x faster linear systems and 200x faster decision-making for defense applications.

• Customer programs are advancing in parallel with product development to ensure market fit.